Skip to main content
Equibles

ACB · Aurora Cannabis Inc

Track ACB — free

Use ACB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.60 +0.68 (+17.35%) At close · Oct 5
Rebalance outlook locked
Market Cap
$256.09M
Shares
63.31M
Volume · Oct 5 4.63M Avg daily vol (3M) 1.29M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$3.92 Open$3.94 Day$3.87–3.97 52W close$2.58–6.17 Avg vol 30d955K Short int7.4M · 11.8% float · 8.5d Short vol43% Last earningsAug 5, 2026 DataJan 2020–Oct 2026

Up next

Next earnings call
Nov 23, 2026 Est · unconfirmed · in 7 wks
Q2 2026 earnings call transcript
call held Sep 30, 2025

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-31.0%
Trailing year
Short interest
11.8%
Latest settlement · 8.5 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.59
Technical
price trend
Buy
50 / 200-day cross Golden cross
Price vs 200-day avg +10%
above
Price vs 50-day avg +7%
above
RSI (14) 51
neutral
MACD trend Negative
52-week position 37%
mid-range
Momentum
relative strength
Neutral
1-month return +1%
trailing
6-month return +13%
trailing
YTD return −7%
this year
Relative strength 0%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) Golden cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow Flat
1 of 153 funds reported for Sep 30 · net 0 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
11.76% of float · ▲ +1.8% MoM · 8.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
153 holders — near 3-yr low, contrarian setup
Squeeze score 86
high risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 57%
annualized · 1-yr
Max drawdown −58%
past year
ATR 3.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Dec 31, 2021
by the first half of fiscal 2023
Annualized cost savings $150M – $170M
annualized basis
Cost savings $150M – $170M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 2 · 3
50 / 200-day cross
Golden cross Bullish
Price vs 200-day avg
+10% Bullish
Price vs 50-day avg
+7% Bullish
RSI (14)
51 Neutral
MACD trend
Negative Bearish
52-week position
37% Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) Golden cross
50d $4 › 200d $4 — 50d above 200d
Institutional flow Flat
1 of 153 funds reported for Sep 30 · net 0 sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
11.76% of float · ▲ +1.8% MoM · 8.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
153 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $3 Now $4 · 37% Range high $6
vs 200-day avg +10% vs 50-day avg +7% 50-day above 200-day golden cross

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
ACB
Aurora Cannabis Inc
this stock
$256.09M -7.1% — — 11.8%
TAK
Takeda Pharmaceutical Co Ltd
 $60.23B +14.6% — — 0.1%
GALDY
Galderma Group AG/ADR
 $46.00B -6.5% — — 0.0%
TEVA
Teva Pharmaceutical Industries Ltd
 $45.67B +26.7% +4.3% 64.3 2.7%
HLN
Haleon plc
 $40.72B -13.0% — — 0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders
Holders
153
% held
10.1%
Reported
1 of 153
Top holder
GOLDMAN SACHS GROUP INC
Held Float
View
Held by Funds
Fund positions
17
View
Short & Settlement
Short Interest Rising
Shares short
7.4M
Days to cover
8.5d
Change
+132.9K sh
View
Short Volume
Short vol %
43%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
13
Value
$48
As of
Sep 11, 2026
View
Off-Exchange
Off-exchange %
42.6%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
John A. Yarmuth
Amount
$1.0K–$15.0K
Traded
Feb 12, 2021
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 24, 2026
This year
37
View
Earnings & Events
Webcasts
Last webcast
Aug 5, 2026
View

Performance

5D 20D 120D MTD YTD
ACB -4.4% +0.8% +12.6% +0.5% -7.1%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -4.2% +1.2% +0.5% -0.4% -20.0%
Key facts CIK 1683541 CUSIP 05156X850 13F (30d) 2 filings 2 filers Visit website